Jefferies Downgrades Cross Country Healthcare to Hold, Lowers Price Target to $21
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Brian Tanquilut has downgraded Cross Country Healthcare (NASDAQ:CCRN) from Buy to Hold and lowered the price target from $32 to $21.
November 03, 2023 | 10:09 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cross Country Healthcare has been downgraded from Buy to Hold by Jefferies, with a lowered price target of $21.
The downgrade from Buy to Hold by Jefferies indicates a less optimistic outlook for the company. The lowered price target from $32 to $21 suggests that the analyst believes the stock is overvalued at its current price, which could lead to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100